Osaic Holdings’s Unicycive Therapeutics UNCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.97K Sell
633
-1
-0.2% -$5 ﹤0.01% 7201
2026
Q2
$2.97K Buy
+634
New +$4.68K ﹤0.01% 7144
2023
Q2
– Hold
0
– -$2 – 7584
2023
Q1
– Hold
0
– – – 7482

Other funds holding UNCY

Osaic Holdings's UNCY Position: Q3 2026 in Review

Osaic Holdings reduced its Unicycive Therapeutics (UNCY) stake by 0.16% in Q3 2026, selling an estimated $5 and leaving 633 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #7201.

Osaic Holdings first reported a position in UNCY in Q2 2026 and has held it in 2 quarters since. The position peaked at $2.97K in Q2 2026. 95 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • Osaic Holdings held 633 shares of Unicycive Therapeutics worth $2.97K as of Q3 2026.
  • Osaic Holdings sold 1 Unicycive Therapeutics share in Q3 2026, an estimated $5.
  • Unicycive Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7201 holding.
  • Osaic Holdings first reported a position in Unicycive Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Osaic Holdings's Unicycive Therapeutics position peaked at $2.97K in Q2 2026.
  • 95 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.